Category Archives: General Legal News

General Legal News from Leading National Class Action Firm Gilman Law LLP

DIABETES MEDICATIONS ONGLYZA AND NESINA ALERT

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Onglyza and Nesina May Increase the Risks of Pancreatic Cancer, Thyroid Cancer and Heart Failure

A FDA advisory committee voted to update the label for Onglyza to warn patients of an increased risk of heart failure. These drugs have also been linked to pancreatic cancer and thyroid cancer.

If you or a family member has taken Onglyza and/or Nesina and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits involving defective drugs.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its

About Onglyza and Nesina

Onglyza (saxagliptin), manufactured by AstraZeneca and Bristol-Myers Squibb, and Nesina (alogliptin), manufactured by Takeda Pharmaceuticals, are approved by the FDA to help those with diabetes maintain a healthy blood sugar level. These drugs belong to a class called incretin mimetics, which stimulates the production of insulin to help regulate blood sugar in patients with type-2 diabetes.

The makers of Onglyza funded a study which found patients who used the drug had a higher rate of hospitalizations due to heart failure. In April 2015, an advisory committee to the FDA voted to update the label for Onglyza to add information regarding the increased risk of heart failure.

A March 2013 study showed a strong link between these diabetes medications and pancreatic cancer. This study also showed that those who had taken these medications had a pancreas that was 40% larger than normal and had a 6x increase of pre-cancerous cell growth and tumors. These tumors can become cancerous. In 2011, the FDA issued a safety warning after studies showed a higher rate of thyroid cancer in rodents taking incretin mimetics.

JANUVIA, BYETTA, JANUMET AND VICTOZA ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuits Filed Against the Makers of the Diabetes Drugs Januvia, Byetta, Janument and Victoza Claiming They Cause Serious Side Effects Such as Pancreatitis and Pancreatic Cancer

According to class action lawsuits filed nationwide against Merck, Amylin, Eli Lilly, Bristol-Myers Squibb and Novo Nordisk A/S, the makers of the diabetes drugs Januvia, Byetta, Janument and Victoza, the companies marketed these medicines as safe knowing they were dangerous and failed to warn the public of the increased risks of pancreatic cancer and pancreatitis.

If you or a family member has taken Januvia, Byetta, Janumet and/or Victoza and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits involving defective drugs.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Januvia, Janument, Byetta and Victoza

Januvia, Byetta, Janumet and Victoza are prescription drugs used to treat Type 2 diabetes. Merek is the maker of Januvia and Janument. Byetta is manufactured Amylin, Eli Lilly and Bristol-Myers Squibb. Victoza is manufactured by Novo Nordisk A/S. The FDA approved the use of Byetta, Januvia, Janument and Victoza in 2005, 2006, 2007 and 2010, respectively. All of these drugs are classified as incretin mimetics. The FDA has issued warnings stating these drugs can cause serious medical problems such as pancreatic diseases.

Plaintiffs in class action lawsuits filed nationwide against the makers of these drugs have claimed they developed pancreatitis and pancreatic cancer due to the use of the drugs. Plaintiffs also allege the drugmakers knew or should have known about the dangerous side effects, failed to test the drugs adequately and monitor the side effects and failed to warn the public of the increased risks of developing pancreatic diseases and cancer.

ALERT: HIGH LEVELS OF ARSENIC FOUND IN NUMEROUS WINES PRODUCED IN CALIFORNIA

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuit Alleging Numerous California Wineries Knowingly Distributed and Sold Wine Containing High Levels of Arsenic

According to the class action complaint filed March 20, 2015, a number of California wineries produced and marketed wines which contained high levels of inorganic arsenic. Inorganic arsenic has proven to cause cancer and contributes to numerous other fatal ailments. Despite this, the defendants continued to manufacture, market and sell these wines while failing to warn the public of the dangers of ingesting inorganic arsenic.

If you or a family member has consumed any of the wines listed below and have become ill, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in toxic substance lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Arsenic in Many Wines Produced in California

A class action complaint was filed on March 20, 2015 in the United States District Court for the Northern District of Florida alleging a number of California wineries of manufacturing and selling wines which, as the result of testing from three different laboratories, contain dangerously high levels of inorganic arsenic. According to the complaint, ingestion of high levels of inorganic arsenic can lead to cancer and a host of other debilitating and/or fatal diseases. Despite this, the wineries listed in the complaint continued to manufacture and sell these wines and failed to warn the public of the potential dangers of inorganic arsenic ingestion.

The following wineries and their wines are subject to the class action lawsuit:

The Wine Group, Inc.

Franzia wine: Vintner Select White Grenache, White Zinfandel, Vintner Select White Merlot and Vintner Select Burgundy
Mogen David wine: Concord and Blackberry wine
Concannon wine: Glen Ellen Reserve Pinot Grigio, Selected Vineyards Pinot Noir and Glen Ellen Reserve Merlot
Flipflop wine: Pinot Grigio, Moscato and Cabernet Sauvignon
Tribuno wine: Sweet Vermouth
Corbett Canyon wine: Pinot Grigio and Cabernet Sauvignon
Alamaden wine: Heritage White Zinfandel; Heritage Moscato; Heritiage Chardonay; Mountain Burgundy; Mountain Rhine and Mountain Chablis
Oak Leaf wine: White Zinfandel
Foxhorn wine: White Zinfandel
Trapiche wine: Malbec
Fisheye wine: Pinot Grigio
Bay Bridge wine: Chardonay
Cupcake wine: Malbec

Sutter Home Winery, Inc.

Ménage a Trois wine: Pinot Grigio, Moscato, While Blend, Chardonnay, Rose, Cabernet Sauvignon and California Red Wine
Wine Cube Wine: Moscato, Pink Moscato, Pinot Grigio, Chardonnay, Red Sangria, Sauvignon Blanc and Cabernet Sauvignon/Shiraz
Bandit wine: Pinot Grigio, Chardonnay and Cabernet Sauvignon
Sutter Home Wine: Sauvignon Blanc, Gewurztraminer, Pink Moscato, Pinot Grigio, Moscato, Chenin Blanc, Sweet Red, Riesling, White Merlot, Merlot, White Zinfandel and Zinfandel
SeaGlass wine: Sauvignon Blanc

Wine Estates Americas Co.

Beringer wine: White Merlot, White Zinfandel, Red Moscato and Refreshingly Sweet Moscato

Constellation Wines and US and Smith & Hook Winery Corporation

HRM Rex-Goliath wine: Moscato
Simply Naked wine: Moscato
Vendange wine: Merlot and White Zinfandel
Cooks wine: Spumante
Richard Wild Irish Rose wine: Red wine

Fetzer Vineyards

Korbel wine: Sweet Rose Sparkling Wine and Extra Dry Sparkling Wine

Mason Cellars and Oakville Winery

Pomelo wine: Sauvignon Blanc

Winery Exchange

Acronym wine: Gr8rw Red Blend
Arrow Creek wine: Coastal Series Cabernet Sauvignon
Hawkstone wine: Cabernet Sauvignon

Treasury Wine Estates

Colores Del Sol wine: Malbec

Don Sebastiani & Sons

Smoking Loon wine: Viognier

Bronco Wine Company

Charles Shaw wine: White Zinfandel

Jean-Claude Boisset Wines

R. Collection by Raymond wine: Chardonay

COX COMMUNICATIONS INC. LAWSUIT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES – WE ARE AVAILABLE TO ASSIST YOU IN SEEKING RECOVERY

Class Action Lawsuit Filed Against Cox Communications Alleging False and Misleading Advertisement of Fees Charged For Certain Cable Television Service Tiers

According to a complaint filed on July 7, 2015, Cox Communications charged its customers unauthorized fees for its “Advanced TV” package.

If you or a family member currently subscribe to or have subscribed to “Adavnced TV” tier with Cox Communications and were charged extra and/or hidden fees, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

COX COMMUNICATIONS INC. LAWSUIT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in product liability and consumer lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About The Class Action Lawsuit Against Cox Communications

A Class Action complaint was filed against Cox Communications, Inc. on July 7, 2015 in the United States District Court for the Southern District of California alleging the defendants engaged in false and misleading advertising when it charged its subscribers of the “Advanced TV” tier extra, hidden fees. The complaint claims Cox Communications advertised prices for television services as all-inclusive, except for government-mandated fees, when it actually charged their subscribers additional and unauthorized fees that the company failed to disclose in its advertisements. The plaintiffs claim Cox Communications deliberately used confusing labeling of these fees for “Advanced TV” and thus was able to make sizable profits.

SIMILAC® ADVANCE ORGANIC INFANT FORMULA ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuit Filed Against Abbott Laboratories Alleging False and Misleading Representations on Labeling of Similac® Advance Organic Infant Formula

According to a complaint filed on May 15, 2015, Abbott’s Similac® Advance “Organic” Infant Formula contains a substantial amount of ingredients prohibited in organic foods. Over half of the ingredients in the “organic” formula are alleged to contain irradiated substances, synthetic compounds or are produced from hazardous products.

If you or a family member has purchased Similac® Advance Organic Infant Formula and did so believing the product was indeed organic, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

SIMILAC® ADVANCE ORGANIC INFANT FORMULA ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in product liability and consumer lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About The Class Action Lawsuit Against Abbott Laboratories

A Class Action complaint was filed against Abbott Laboratories on May 15, 2015 in the United States District Court for the Eastern District of New York alleging the defendant engaged in false and misleading advertising when it labeled its Similac® Advance Organic Infant Formula as organic. Plaintiffs allege over half of the ingredients in the “Organic” formula contain substances prohibited in organic foods. Because of these false and misleading statements, Plaintiffs allege that Abbott Laboratories was able to ask for and obtain a premium price for the formula marketed under the organic guise and make sizable profits. Plaintiffs further allege that the Defendant violated various consumer protection states laws.

XOLAIR SIDE EFFECTS ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Xolair Can Increase the Risk of Severe Heart Problems, Brain and Blood Vessel Problems and Cancer

According to class action lawsuits filed against Genentech and Novartis, the makers and marketers of Xolair, the companies knew of the serious risks of the medication but failed to warn the public.

If you or a family member has taken Xolair and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

XOLAIR SIDE EFFECTS ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits involving defective drugs.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its

About Xolair

Xolair (omalizumab) was approved by the FDA in 2003 to treat patients 12 years and older with moderate to severe asthma caused by allergens also called allergic asthma. Xolair is an injection which helps reduce the number of asthma attacks for those who are still suffering from asthma symptoms even though they are taking inhaled steroids. Xolair is also approved for use with those who suffer from chronic hives and are not helped by taking H1 antihistamine treatments.

The possible side effects of Xolair include:

Heart attack
Mini-strokes
Transient ischemic attacks (TIAs)
Chest pain
Pulmonary hypertension
Blood clots in lungs and veins
Cancer

In 2009, the FDA required the makers of Xolair, Grenentech, Inc., to perform a 5-year study regarding the safety of the drug. Due to the data from this study, the FDA ruled in September 2014 that new warnings on Xolair package inserts and prescribing information need to be added detailing the risks of serious complications caused by the drug’s side effects. During the same time, the FDA issued a drug safety warning that Xolair’s side effects can cause the serious complications listed above. The new safety warnings join a black box warning added in 2007 regarding the risk of severe and life threatening allergic reaction called anaphylaxis.

SLING MEDIA INC. LAWSUIT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES – WE ARE AVAILABLE TO ASSIST YOU IN SEEKING RECOVERY

Class Action Lawsuit Filed Against Sling Media Alleging Misrepresentation of Service and Unfair Business Practice

According to a complaint filed on July 10, 2015, Sling Media broadcasted advertisements on its Slingbox device without prior notice or permission from its customers.

If you or a family member has purchased a Sling Media device prior to March 17, 2015, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

SLING MEDIA INC. LAWSUIT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in consumer lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About The Class Action Lawsuit Against Sling Media

A Class Action complaint was filed against Sling Media on July 10, 2015 in the United States District Court for the Southern District of New York alleging the defendant engaged in misrepresentation of service and unfair business practice when it posted original advertisements on its Slingbox device without prior notice or consent of the consumer. The plaintiffs state their devices, which stream television content onto a user’s mobile device, tablet or laptop, were free of advertisements up until March 17, 2015. The complaint contends this is a classic “bait and switch” in that owners of the Slingbox must now watch the advertisements in order to use their devices as promised.

CNA INSURANCE: BREACH OF TERMS OF LONG TERM CARE POLICIES ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES – WE ARE AVAILABLE TO ASSIST YOU IN SEEKING RECOVERY

Lawsuit filed against CNA Financial Corp. and Continental Casualty Company (“CNA”) Alleging Breach of the Terms of Long Term Care Insurance Policies by Excluding Coverage at Assisted Living Facilities

According to the complaint filed on May 18, 2015, CNA is breaching the terms of its long term care policies by denying coverage for all claims filed for stays at assisted living facilities.

If you or a family member has a long term care policy with CNA, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

CNA INSURANCE

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits against insurance companies.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About CNA’s Breach of Terms of Its Long Term Care Policies

A complaint was filed on May 18, 2015 in the United States District Court for the Western District of Wisconsin accusing CNA of breaching its terms of their long term care policies. Plaintiff claims CNA is misrepresenting the Wisconsin statutory definition for assisted living facilities and the requirements of its long term care policies to justify denying all claims at the state’s assisted living facilities. To qualify for benefits of a CNA long term care policy, you must show that you are medically eligible and the long term care facility meets the policy’s definition of such. At issue in this lawsuit is the definition of 24- hour-a-day nursing service and whether any Wisconsin assisted living facility can meet this requirement. Plaintiff alleges CNA is wrongfully stating that no Wisconsin assisted living facility can meet the 24-hour-a-day nursing service requirement. Plaintiff further states CNA is denying to pay claims at facilities in which they had paid in the past. Plaintiff adds that CNA also requested and received a 45% rate increase on these very policies.

C-QUR MESH ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuits Filed Nationwide on Behalf of Victims Injured by C-QUR Mesh

According to multiple class action lawsuits filed across the country, C-QUR Mesh failures have caused serious side effects including infections, internal injuries and mesh adhesion

If you or a family member has or had a C-QUR Mesh implanted and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

C-QUR MESH ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in medical device lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About C-QUR Mesh

C-QUR Mesh is manufactured by Atrium Medical Corporation and was approved by the FDA in 2006 for hernia repair, chest wall reconstruction and the repair of surgical wounds. In July 2013, Atrium voluntarily recalled the hernia repair implants due to the coating of C-QUR Mesh sticking to the inner package lining when exposed to excessive humidity for an extended period of time.

Class action lawsuits have been filed nationwide against Atrium alleging plaintiffs have suffered serious side effects due to the implantation of C-QUR Mesh. Many plaintiffs have experienced infections, internal injuries to nearby organs, nerves and/or blood vessels, mesh adhesion to the intestines, chronic pain and recurring hernia. The numerous lawsuits claim Atrium failed to conduct adequate research and testing of the C-QUR Mesh and misled the public when it marketed the product as safe and effective knowing it could cause serious medical problems.

BEYAZ ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Lawsuits Are Being Filed Against Bayer, the Makers of Beyaz, Claiming Serious Complications

According to class action lawsuits filed nationwide, Beyaz has caused women to have serious side effects including gallbladder disease, stroke, blood clots and death.

If you or a family member have or currently use Beyaz and have been injured, you may be entitled to compensation.

Bayer paid $1.4 billion to settle close to 7,000 blood clot lawsuits

Bayer has created a fund of $24 million for gallbladder claims for more than 8,000 plaintiffs

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

BEYAZ ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in medical device lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Beyaz

Beyaz is an oral contraceptive which is prescribed to avoid pregnancy. It is the “sister” medication to Yaz and Yasmin. All are manufactured by Bayer Pharmaceuticals.

All oral contraceptives contain ethinyl estradiol, a man-made estrogen-like hormone that increases clotting factors in the blood. Some studies show that the newer contraceptives with third and fourth generation progestins have a different reaction with ethinyl estradiol and carries a greater risk than older medications. Beyaz contains drospirenone, a fourth generation progestin.

Beyaz and other oral contraceptives containing drospireone have caused women serious side effects such as gallbladder disease, stroke, blood clots and death. Many women who have suffered from these adverse effects have filed class action lawsuits claiming they were not adequately warned of the dangers of taking Beyaz and Bayer knew or should have known about these dangerous side effects.